PRWeb The Leader Press Release Distribution
See How PRWeb Works

We're here to help 1-866-640-6397

Login Create Free Account


All Press Releases for May 31, 2002 Subscribe to this News Feed    
 

May 31 2002 Anthrax-New Technology;Patent Pending Biosafe Mailbox Systems going public to seek funding

Independent product developer has patent pending technology to fight against cross-contamination of Anthrax in U.S. mail. Will be seeking funding for start up or licensing to Biofirms.

Gary mize and co-inventor Brandy Mize have decided to go public to offer their Patent pending technology against Terror mailers. Biosafe Mailbox Systems offers a solution to eliminate cross-contamination of Anthrax and other biohazards in the mail. Mr. and Mrs Mize are actively seeking funding or licensing of this technology. The following is a summary of technology. Patent Pending Bio-safe safe mailbox. In view of foregoing disadvantages inherent in the known procedures to handle and eradicate infectious agents,the present invention provides a method and apparatus to eliminate biological agents before the mail comes in contact with the postal facility worker and/or mail recipient. To attain this,the present invention comprises a bio-safe device that delivers a timed application of a decontaminant in an enclosed structure,or mailbox,to destroy biological agents on contaminated mail. In the first embodiment of the invention,the bio-safe device is configured to be readily installed in the common residential mailbox. In a second embodiment of the invention, the bio-safe device is installed in the U.S. Post Office mailbox. In a third embodiment of the invention,the bio-safe device is installed in the mail sorting center. The bio-safe device is entirely managed by the owner. The bio-safe device is chemically charged and functionally checked on a periodic basis for operability. The bio-safe device is configured to discharge the decontaminant on a daily basis for a set duration of time to effectively eliminate the biological agent after each [daily] mail delivery. Consequently,the recipient and mail carrier is made aware of the eradication process through indication of the bio-safe activity status clearly indicated on the mailbox to facilitate safe and complete operation. It is to be understood that the invention is not limited in its application to the details of construction and to the arrangements of the components set forth in the following description. The invention is capable of other embodiments and of being practiced and carried out in various ways.Also,it is to be understood the phraseology and terminology herin are for the purpose of the description and should not be regarded as limiting. A primary object of the present invention is to provide a method and apparatus to protect the general public against exposure to infectious agents on contaminated mail. An object is to provide the method and apparatus for the individual mail recipient to destroy infectious agents before physical contact with the mail. Another object is to provide a method and apparatus for the postal carrier or individual mail recipient to destroy infectious agents without destroying the mail. Another object is to provide a method and apparatus for the postal carrier or individual mail recipient to inexpensively self manage the destruction of infectious agents. There are many claims and descriptions included that become obvious.Interested parties are invited to contact Mr. Mize by email at gwmizer@bellsouth.net to discuss aspects of this innovating technology,available for sale or licensing.

OPTIONS
Printer Friendly Version
Email this story to a colleague
CONTACT INFORMATION
Gary Mize
Email us Here
ATTACHED FILES

There are no multimedia files attached to this release. If this is your release, you may add images or other multimedia files through your PRWeb News Management Console.

ABOUT PRESS RELEASES
If you have any questions regarding information in these press releases please contact the company listed in the press release. Please do not contact PRWeb. We will be unable to assist you with your inquiry. PRWeb disclaims any content contained in these release. Our complete disclaimer appears here.